Tag - Robert Foster

Executive Moves

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Stephen Harrison Hepion Pharmaceuticals (NASDAQ:HEPA) appointed world-renowned Dr. Stephen Harrison as consultant medical director. Dr. Harrison is a peer-reviewer for more than 20 medical journals. He is...

October 10, 2019

Feature

Robert Foster swinging for the fence again with ContraVir Pharma

Dr. Robert Foster is teeing up another possible home run as the new CEO of ContraVir Pharmaceuticals (NASDAQ:CTRV) and its lead programs for liver disease arising from chronic viral infection and NASH (non-alcoholic...

November 13, 2018

Tag - Robert Foster

Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director

Robert Foster swinging for the fence again with ContraVir Pharma

General

More